Cancer glossary
Tumor regression grade: what TRG, Miller–Payne and RCB mean
Tumor regression is how a tumor changed under treatment, as seen by the pathologist in removed tissue. How to read the Lavnikova grades, CAP TRG 0–3, Miller–Payne and RCB.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
Tumor regression (in Russian reports, ‘therapeutic pathomorphosis’) means the changes in a tumor caused by treatment: death of tumor cells, necrosis, replacement by scar tissue. The pathologist assesses it in tissue removed after neoadjuvant therapy and records a grade on one of several scales.
How it appears in your report
- ‘Therapeutic pathomorphosis, grade III (Lavnikova)’ — common in Russian-language reports.
- ‘Rectal adenocarcinoma with minimal response to treatment (CAP grade 2)’.
- ‘Miller–Payne grade 4’ — in breast cancer.
- ‘RCB-II’ — residual cancer burden in breast cancer.
- ‘No viable tumor cells identified’, ‘ypT0 ypN0’ — complete response; see pCR.
What it means
There are several scales, and they run in different directions:
| Scale | Complete response | Weak or no response |
|---|---|---|
| Lavnikova, I–IV | IV — tumor tissue has completely disappeared | I — no notable change in tumor structure |
| CAP (TRG), 0–3 | 0 — no viable cancer cells | 3 — minimal or no tumor kill, extensive residual cancer |
| Miller–Payne, 1–5 (breast) | 5 — no tumor cells found | 1 — changes in some cells, no drop in their number |
| RCB (breast) | pCR (RCB-0) | RCB-III — extensive residual cancer |
The middle grades describe how much tumor is left. On the CAP scale, 1 means single cells or small clusters remain, and 2 means residual cancer with predominant fibrosis. In Miller–Payne grade 4, more than 90% of tumor cells are gone. RCB is calculated from the size of the residual tumor, the share of invasive cancer and lymph node involvement. International ICCR guidance for stomach cancer recommends assessing regression only in the primary tumor, because there is no validated method for lymph nodes.
Does it affect treatment
Yes, for some tumors. Together with ypTNM, the regression grade helps show how sensitive the tumor was to the treatment given and is taken into account when choosing treatment after surgery. Different labs and scales do not always agree, so if in doubt you can request a slide review. Your treating doctor or tumor board decides on further therapy.
Questions to ask your doctor
- Which scale was used, and what does my grade mean?
- How does the result affect treatment after surgery?
- Is there any tumor left in the lymph nodes after treatment?
If you are unsure what comes next after surgery, we can discuss it in a consultation during treatment.
Sources
- Лечебный патоморфоз злокачественных опухолей: клинические и морфологические критерии. Классификации — Lisaeva A.A. et al., Tumors of Female Reproductive System journal, 2011
- College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer — The Oncologist, 2021
- Carcinoma of the Stomach: Response to neoadjuvant therapy — International Collaboration on Cancer Reporting (ICCR), 2021
- Residual Cancer Burden Can Predict Outcomes for Patients With Any Breast Cancer Type — American Association for Cancer Research (AACR), 2019
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
